• JAMA · Jan 2025

    Palliative Care Initiated in the Emergency Department: A Cluster Randomized Clinical Trial.

    • Corita R Grudzen, Nina Siman, Allison M Cuthel, Oluwaseun Adeyemi, Rebecca Liddicoat Yamarik, Keith S Goldfeld, PRIM-ER Investigators, Benjamin S Abella, Fernanda Bellolio, Sorayah Bourenane, Abraham A Brody, Lauren Cameron-Comasco, Joshua Chodosh, Julie J Cooper, Ashley L Deutsch, Marie Carmelle Elie, Ahmed Elsayem, Rosemarie Fernandez, Jessica Fleischer-Black, Mauren Gang, Nicholas Genes, Rebecca Goett, Heather Heaton, Jacob Hill, Leora Horwitz, Eric Isaacs, Karen Jubanyik, Sangeeta Lamba, Katharine Lawrence, Michelle Lin, Caitlin Loprinzi-Brauer, Troy Madsen, Joseph Miller, Ada Modrek, Ronny Otero, Kei Ouchi, Christopher Richardson, Lynne D Richardson, Matthew Ryan, Elizabeth Schoenfeld, Matthew Shaw, Ashley Shreves, Lauren T Southerland, Audrey Tan, Julie Uspal, Arvind Venkat, Laura Walker, Ian Wittman, and Erin Zimny.
    • Division of Supportive and Acute Care Services, Memorial Sloan Kettering Cancer Center, New York, New York.
    • JAMA. 2025 Jan 15.

    ImportanceThe emergency department (ED) offers an opportunity to initiate palliative care for older adults with serious, life-limiting illness.ObjectiveTo assess the effect of a multicomponent intervention to initiate palliative care in the ED on hospital admission, subsequent health care use, and survival in older adults with serious, life-limiting illness.Design, Setting, And ParticipantsCluster randomized, stepped-wedge, clinical trial including patients aged 66 years or older who visited 1 of 29 EDs across the US between May 1, 2018, and December 31, 2022, had 12 months of prior Medicare enrollment, and a Gagne comorbidity score greater than 6, representing a risk of short-term mortality greater than 30%. Nursing home patients were excluded.InterventionA multicomponent intervention (the Primary Palliative Care for Emergency Medicine intervention) included (1) evidence-based multidisciplinary education; (2) simulation-based workshops on serious illness communication; (3) clinical decision support; and (4) audit and feedback for ED clinical staff.Main Outcome And MeasuresThe primary outcome was hospital admission. The secondary outcomes included subsequent health care use and survival at 6 months.ResultsThere were 98 922 initial ED visits during the study period (median age, 77 years [IQR, 71-84 years]; 50% were female; 13% were Black and 78% were White; and the median Gagne comorbidity score was 8 [IQR, 7-10]). The rate of hospital admission was 64.4% during the preintervention period vs 61.3% during the postintervention period (absolute difference, -3.1% [95% CI, -3.7% to -2.5%]; adjusted odds ratio [OR], 1.03 [95% CI, 0.93 to 1.14]). There was no difference in the secondary outcomes before vs after the intervention. The rate of admission to an intensive care unit was 7.8% during the preintervention period vs 6.7% during the postintervention period (adjusted OR, 0.98 [95% CI, 0.83 to 1.15]). The rate of at least 1 revisit to the ED was 34.2% during the preintervention period vs 32.2% during the postintervention period (adjusted OR, 1.00 [95% CI, 0.91 to 1.09]). The rate of hospice use was 17.7% during the preintervention period vs 17.2% during the postintervention period (adjusted OR, 1.04 [95% CI, 0.93 to 1.16]). The rate of home health use was 42.0% during the preintervention period vs 38.1% during the postintervention period (adjusted OR, 1.01 [95% CI, 0.92 to 1.10]). The rate of at least 1 hospital readmission was 41.0% during the preintervention period vs 36.6% during the postintervention period (adjusted OR, 1.01 [95% CI, 0.92 to 1.10]). The rate of death was 28.1% during the preintervention period vs 28.7% during the postintervention period (adjusted OR, 1.07 [95% CI, 0.98 to 1.18]).Conclusions And RelevanceThis multicomponent intervention to initiate palliative care in the ED did not have an effect on hospital admission, subsequent health care use, or short-term mortality in older adults with serious, life-limiting illness.Trial RegistrationClinicalTrials.gov Identifier: NCT03424109.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!

We guarantee your privacy. Your email address will not be shared.